Back to Journals » International Journal of Nanomedicine » Volume 9 » Issue 1

Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides

Authors Vacas-Córdoba E, Galán M, de la Mata J, Gómez R, Pion M, Muñoz-Fernández MA

Received 18 February 2014

Accepted for publication 23 March 2014

Published 29 July 2014 Volume 2014:9(1) Pages 3591—3600


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Enrique Vacas-Córdoba,1–3 Marta Galán,3,4 Francisco J de la Mata,3,4 Rafael Gómez,3,4 Marjorie Pion,1–3 M Ángeles Muñoz-Fernández1–3

1Laboratorio InmunoBiología Molecular, Hospital General Universitario Gregorio Marañón, Madrid, Spain; 2Instituto de Investigación Sanitaria del Gregorio Marañón, Madrid, Spain; 3Networking Research Center on Bioengineering, Biomaterials and Nanomedicine, (CIBER-BBN), Madrid, Spain; 4Dendrimers for Biomedical Applications Group (BioInDen), University of Alcalá, Madrid, Spain

Abstract: Self-administered topical microbicides or oral preexposure prophylaxis could be very helpful tools for all risk groups to decrease the human immunodeficiency virus (HIV)-1 infection rates. Up until now, antiretrovirals (ARVs) have been the most advanced microbicide candidates. Nevertheless, the majority of clinical trials has failed in HIV-1 patients. Nanotechnology offers suitable approaches to develop novel antiviral agents. Thereby, new nanosystems, such as carbosilane dendrimers, have been shown to be safe and effective compounds against HIV with great potential as topical microbicides. In addition, because most of the attempts to develop effective topical microbicides were unsuccessful, combinatorial strategies could be a valid approach when designing new microbicides. We evaluated various combinations of anionic carbosilane dendrimers with sulfated (G3-S16) and naphthyl sulfonated (G2-NF16) ended groups with different ARVs against HIV-1 infection. The G3-S16 and G2-NF16 dendrimers showed a synergistic or additive activity profile with zidovudine, efavirenz, and tenofovir in the majority of the combinations tested against the X4 and R5 tropic HIV-1 in cell lines, as well as in human primary cells. Therefore, the combination of ARVs and polyanionic carbosilane dendrimers enhances the antiviral potency of the individual compounds, and our findings support further clinical research on combinational approaches as potential microbicides to block the sexual transmission of HIV-1.

Keywords: microbicides, HIV, carbosilane dendrimer, antiretroviral, synergy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Other articles by this author:

Efficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semen

Ceña-Diez R, García-Broncano P, de la Mata FJ, Gómez R, Muñoz-Fernández MA

International Journal of Nanomedicine 2016, 11:2443-2450

Published Date: 30 May 2016

Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action

Ceña-Diez R, Vacas-Córdoba E, García-Broncano P, de la Mata FJ, Gómez R, Maly M, Muñoz-Fernández MA

International Journal of Nanomedicine 2016, 11:2147-2162

Published Date: 19 May 2016

Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1

Vacas-Córdoba E, Maly M, De la Mata FJ, Gómez R, Pion M, Muñoz-Fernández MA

International Journal of Nanomedicine 2016, 11:1281-1294

Published Date: 5 April 2016

Readers of this article also read:

Molecular targets in arthritis and recent trends in nanotherapy

Roy K, Kanwar RK, Kanwar JR

International Journal of Nanomedicine 2015, 10:5407-5420

Published Date: 26 August 2015

Delivery as nanoparticles reduces imatinib mesylate-induced cardiotoxicity and improves anticancer activity

Marslin G, Revina AM, Khandelwal VKM, Balakumar K, Prakash J, Franklin G, Sheeba CJ

International Journal of Nanomedicine 2015, 10:3163-3170

Published Date: 24 April 2015

Photothermal killing of Staphylococcus aureus using antibody-targeted gold nanoparticles

Millenbaugh NJ, Baskin JB, DeSilva MN, Elliott WR, Glickman RD

International Journal of Nanomedicine 2015, 10:1953-1960

Published Date: 18 March 2015

Preparation and therapeutic evaluation of 188Re-thermogelling emulsion in rat model of hepatocellular carcinoma

Shih YH, Lin XZ, Yeh CH, Peng CL, Shieh MJ, Lin WJ, Luo TY

International Journal of Nanomedicine 2014, 9:4191-4201

Published Date: 2 September 2014

Manganese ferrite-based nanoparticles induce ex vivo, but not in vivo, cardiovascular effects

Nunes ADC, Ramalho LS, Souza APS, Mendes EP, Colugnati DB, Zufelato N, Sousa MH, Bakuzis AF, Castro CH

International Journal of Nanomedicine 2014, 9:3299-3312

Published Date: 8 July 2014

Detection of PLGA-based nanoparticles at a single-cell level by synchrotron radiation FTIR spectromicroscopy and correlation with X-ray fluorescence microscopy

Pascolo L, Bortot B, Benseny-Cases N, Gianoncelli A, Tosi G, Ruozi B, Rizzardi C, De Martino E, Vandelli MA, Severini GM

International Journal of Nanomedicine 2014, 9:2791-2801

Published Date: 7 June 2014